安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Nuvalent | Precisely targeted therapies for patients with cancer
With deep expertise in chemistry and structure-based drug discovery, Nuvalent is creating precisely targeted therapies for patients with cancer
- Nuvalent Announces Public Offering of Common Stock
Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs
- Nuvalent races to FDA to challenge Pfizer for lung cancer market
Nuvalent has reported phase 1 2 lung cancer data, teeing up talks about a filing that could establish neladalkib as a challenger to Pfizer’s Lorbrena
- Nuvalent Tops A Profit-Taking Zone On Its Unprecedented Test Results . . .
Nuvalent said Monday almost a third of patients with a hard-to-treat form of lung cancer responded to its experimental drug
- Nuvalent (NUVL) Stock Price Overview
A detailed overview of Nuvalent, Inc (NUVL) stock, including real-time price, chart, key statistics, news, and more
- NUVL Stock Price | Nuvalent Inc. Cl A Stock Quote (U. S. : Nasdaq . . .
Nuvalent, Inc is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2
- Nuvalent says ALK+ targeted lung cancer drug succeeds in trial | STAT
Nuvalent said its drug for ALK+ lung cancer shrank tumors in more than a quarter of patients whose disease had returned after trying other targeted medicines
- Chasing rivals, Nuvalent to seek approval of targeted lung cancer drug
A targeted lung cancer drug from Nuvalent led to tumor responses in about half of people who previously received at least one therapy like it, and 44% of those who had received at least two similar medicines, according to results from a clinical trial the company shared Tuesday
|
|
|